Investing

For One Seasoned Pro, It's Good Riddance to 2011

Brian Rogers, manager of T.

Brian Rogers, manager of T. Rowe Price Equity Income, says 2011 was “absolutely miserable.” Truth be told, the past year was hardly a disaster for the fund, but the result was ho-hum for Rogers, who has produced a respectable 15-year return at Equity Income of 6.1% annualized. He blames the market’s wacky reaction to problems in Europe and Washington, D.C., not the fund’s size—$21 billion at last report—or the demands of his role as chairman of T. Rowe Price. Meanwhile, he continues to look for large, high-quality, dividend-paying companies with growth potential. “Past performance is no predictor,” says Rogers. “That holds as much when one is down as when one is up.”

Reach your goals. To see portfolios using these funds, go to kiplinger.com/links/portfolios.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
You Can Appeal a Medicare Premium Surcharge
Medicare

You Can Appeal a Medicare Premium Surcharge

If you meet one of the seven qualifying life events, you have a good chance of getting a higher premium for Medicare Part B and Part D reduced.
June 16, 2021
12 Housing Stocks to Ride the Red-Hot Market
investing

12 Housing Stocks to Ride the Red-Hot Market

The U.S. has a housing shortage and a love affair with home improvement, both of which could create tailwinds for this group of housing stocks.
June 8, 2021

Recommended

5 Best Mutual Funds to Fight Inflation
mutual funds

5 Best Mutual Funds to Fight Inflation

These five mutual funds cover a wide variety of asset classes, but they share a similar trait: They're effective hedges against inflation.
June 18, 2021
Vanguard Money Market Funds: What You Need to Know
investing

Vanguard Money Market Funds: What You Need to Know

Vanguard money market funds are a notable asset storage tool. Here, we break down what you need to know about the firm's six offerings.
June 9, 2021
Principal Healthcare Innovators: Earnings Not Wanted
Becoming an Investor

Principal Healthcare Innovators: Earnings Not Wanted

This stock fund uses "counterintuitive" criteria to target small and midsize healthcare companies focused on innovation.
May 27, 2021
Vanguard Short-Term Investment-Grade Keeps It Short and Sweet
Kip 25

Vanguard Short-Term Investment-Grade Keeps It Short and Sweet

This member of the Kiplinger 25 focuses on debt with one- to five-year maturities, making it less sensitive to interest-rate shifts.
May 25, 2021